Pacific Biosciences Of California (PACB) Cash from Operations (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Cash from Operations of 44691000.0 for Q1 2026, down 1.44% year-over-year from 45344572.81 in Q1 2025, and down 134.36% quarter-over-quarter from 19069000.0 in Q4 2025.
Pacific Biosciences Of California (PACB) Cash from Operations (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Cash from Operations history runs 17 years deep, the most recent figure standing at 44691000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 1.44% year-over-year to 44691000.0; the TTM figure through Mar 2026 stood at 111844000.0 (up 35.88% YoY), while the FY2025 annual figure was 111209000.0, up 46.03% from the prior year.
- Cash from Operations for Q1 2026 stood at 44691000.0, down from 19069000.0 in the prior quarter.
- The five-year high for Cash from Operations was 18707000.0 in Q3 2025, with the low at 94691000.0 in Q1 2023.
- The 5-year median for Cash from Operations is 54263000.0 (2024), against an average of 52020117.65.
- The sharpest annual moves came in 2022 and 2025: Cash from Operations tumbled 285.46% in 2022, then soared 58.85% in 2025.
- Pacific Biosciences Of California's Cash from Operations stood at 60566000.0 in 2022, then climbed by 4.96% to 57560000.0 in 2023, then soared by 46.75% to 30650000.0 in 2024, then soared by 37.78% to 19069000.0 in 2025, then sank by 134.36% to 44691000.0 in 2026.
- Business Quant data shows PACB's Cash from Operations at 44691000.0 in Q1 2026, 19069000.0 in Q4 2025, and 18707000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.26 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 651.90 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 269.20 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 168.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 437.05 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 367.10 Mn |
| 10 | Pacific Biosciences Of California | 394.84 Mn | 157.97 Mn | 12.64 Mn | -35.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -35.58 Mn |
| Jun 30, 2026 | -35.58 Mn |
| Mar 31, 2026 | -44.69 Mn |
| Mar 31, 2026 | -44.69 Mn |
| Dec 31, 2025 | -19.07 Mn |
| Dec 31, 2025 | -19.07 Mn |
| Sep 30, 2025 | -18.71 Mn |
| Sep 30, 2025 | -18.71 Mn |
| Jun 30, 2025 | -29.38 Mn |
| Jun 30, 2025 | -29.38 Mn |
| Mar 31, 2025 | -44.06 Mn |
| Mar 31, 2025 | -44.06 Mn |
| Dec 31, 2024 | -30.65 Mn |
| Dec 31, 2024 | -30.65 Mn |
| Sep 30, 2024 | -45.46 Mn |
| Sep 30, 2024 | -45.46 Mn |
| Jun 30, 2024 | -54.26 Mn |
| Jun 30, 2024 | -54.26 Mn |
| Mar 31, 2024 | -75.68 Mn |
| Mar 31, 2024 | -75.68 Mn |